Related Experiment Video
Updated: Apr 26, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Who is using long-acting reversible contraceptive methods? Findings from nine low-fertility countries
Mieke C W Eeckhaut1, Megan M Sweeney, Jessica D Gipson
1California Center for Population Research, University of California, Los Angeles. MEeckhaut@ucla.edu.
Context:
Long-acting reversible contraceptive (LARC) methods-IUDs and implants-are more effective than other reversible methods, yet are little used in the United States. Examining which U.S. women use LARC methods and how they differ from users in other low-fertility countries may help point the way toward increasing use.
Methods:
Data from married or cohabiting women participating in the National Survey of Family Growth (2008-2010) and in eight countries' Generations and Gender Programme surveys (2004-2010) were used in bivariate and multinomial logistic regression analyses examining LARC use within each setting.
Results:
The proportion of contraceptive use accounted for by LARC methods was generally greater in Europe (10-32%) than in the United States (10%) and Australia (7%). Compared with LARC use among comparable groups in other countries, use was particularly low among U.S. women who were married, were aged 40-44 or had had three or more children, yet was comparatively high among 18-24-year-olds. Among U.S. women, those aged 35-39 or 40-44 were more likely than 18-29-year-olds to rely on sterilization rather than on LARC methods (odds ratios, 3.0 and 10.7, respectively), those who had had three or more children were more likely to do so than were those who had had none or one (4.9), and women who had completed college were less likely than those who had not finished high school to do so (0.4).
Conclusions:
Certain subgroups of U.S. women may benefit from the reversibility and effectiveness of LARC methods.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Oral Drug Delivery Systems: Continuous-Release Systems
Modified-Release Drug Delivery Systems: Rate-Programmed II
Retrovirus Life Cycles

